<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Multidiscip Healthc</journal-id><journal-id journal-id-type="iso-abbrev">J Multidiscip Healthc</journal-id><journal-id journal-id-type="publisher-id">JMDH</journal-id><journal-id journal-id-type="pmc">jmulthealth</journal-id><journal-title-group><journal-title>Journal of Multidisciplinary Healthcare</journal-title></journal-title-group><issn pub-type="epub">1178-2390</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6682174</article-id><article-id pub-id-type="publisher-id">175713</article-id><article-id pub-id-type="doi">10.2147/JMDH.S175713</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach</article-title><alt-title alt-title-type="running-authors">Dijk et al</alt-title><alt-title alt-title-type="running-title">Dijk et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dijk</surname><given-names>Dieuwerke R</given-names></name><xref ref-type="corresp" rid="AN0001"/><xref ref-type="aff" rid="AFF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Bocca</surname><given-names>Gianni</given-names></name><xref ref-type="aff" rid="AFF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>van Ravenswaaij-Arts</surname><given-names>Conny M</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref></contrib><aff id="AFF0001"><label>1</label><institution>Department of Genetics, University of Groningen, University Medical Center Groningen</institution>, <addr-line>Groningen</addr-line>, <country>The Netherlands</country></aff><aff id="AFF0002"><label>2</label><institution>Department of Pediatrics, Beatrix Children&#x02019;s Hospital, University of Groningen, University Medical Center Groningen</institution>, <addr-line>Groningen</addr-line>, <country>The Netherlands</country></aff></contrib-group><author-notes><corresp id="AN0001">Correspondence: Dieuwerke R Dijk <institution>Department of Genetics, University of Groningen, University Medical Center Groningen</institution>, <addr-line>Hanzeplein 1, PO Box 30 001</addr-line>, <addr-line>Groningen</addr-line><addr-line>9700</addr-line><addr-line>RB</addr-line>, <country>The Netherlands</country><phone>Tel +31 50 361 7100</phone><fax>Fax +31 50 361 7231</fax>Email <email xlink:href="d.r.dijk@umcg.nl">d.r.dijk@umcg.nl</email></corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>12</volume><fpage>607</fpage><lpage>620</lpage><history><date date-type="received"><day>01</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>12</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Dijk et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Dijk et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><title>Abstract</title><p>CHARGE (Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of growth and/or development, Genital hypoplasia, Ear anomalies including hearing loss) syndrome is a rare syndrome with an incidence of approximately 1:15,000 newborns. It is caused by pathogenic variants in the <italic>CHD7</italic> gene and clinically characterized by a wide range of anomalies with variable expression. Growth retardation affects 60&#x02013;72% of children with CHARGE syndrome, making it one of the most prominent medical issues in the syndrome. Growth retardation in CHARGE syndrome is thought to be multifactorial and can be influenced by almost all co-morbidities, requiring a multidisciplinary approach to the different medical problems. In this systematic review, we describe what is currently known about growth in CHARGE syndrome and how it is influenced by commonly seen clinical problems including feeding difficulties, hypogonadotropic hypogonadism and growth hormone deficiency. Furthermore, we provide recommendations for a multidisciplinary approach.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>CHARGE syndrome</kwd><kwd>growth</kwd><kwd>short stature</kwd><kwd>multidisciplinary</kwd><kwd>hypogonadotropic hypogonadism</kwd></kwd-group><counts><fig-count count="1"/><table-count count="2"/><ref-count count="67"/><page-count count="14"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001"><title>Introduction</title><p>CHARGE syndrome (OMIM 214800) is a rare disorder with an estimated incidence of 1 in 15,000 to 1 in 17,000 live births.<xref rid="CIT0001" ref-type="bibr">1</xref> It is characterized by a wide spectrum of anomalies that vary among patients. In 1981, Pagon introduced the acronym CHARGE based on some of the most prevalent anomalies in the syndrome: Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of growth and/or development, Genital hypoplasia and Ear and hearing abnormalities.<xref rid="CIT0002" ref-type="bibr">2</xref> CHARGE syndrome can be clinically diagnosed by using the Blake or Verloes criteria.<xref rid="CIT0003" ref-type="bibr">3</xref>,<xref rid="CIT0004" ref-type="bibr">4</xref></p><p>In 2004, variants in the <italic>CHD7</italic> gene (OMIM 608892) were identified to be responsible for the CHARGE phenotype.<xref rid="CIT0005" ref-type="bibr">5</xref> Since then, more than 1000 variants in CHD7 have been identified, and a CHD7 variant is found in 83&#x02013;95% of patients fulfilling Blake or Verloes&#x02019; diagnostic criteria.<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref> Next-generation sequencing techniques have led to the identification of an increased number of CHD7 gene variants and to increased detection of these variants in patients with a mild phenotype. The majority of CHD7 gene variants are nonsense or frameshift mutations, while missense and splice site mutations have been detected in a minority of cases, and deletions, duplications and chromosomal rearrangements are rare.<xref rid="CIT0001" ref-type="bibr">1</xref></p><p>CHARGE syndrome is a clinically variable syndrome, and there is no clear correlation between genotype and phenotype when focusing on individual cases. However, patients with a missense mutation generally have a milder phenotype, and missense mutations are more frequently found in patients with Kallmann syndrome.<xref rid="CIT0008" ref-type="bibr">8</xref>&#x02013;<xref rid="CIT0010" ref-type="bibr">10</xref> CHARGE syndrome is thought to be caused by a loss of function of CHD7 and has an autosomal dominant inheritance pattern. Most cases are caused by de novo mutations, although some familiar cases have been reported.<xref rid="CIT0001" ref-type="bibr">1</xref>,<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0012" ref-type="bibr">12</xref></p><p>In 2016, new clinical criteria were proposed that consist of the revised Blake criteria with the addition of a pathogenic variant in the <italic>CHD7</italic> gene as a major criterion.<xref rid="CIT0013" ref-type="bibr">13</xref></p><p>Growth retardation and hypogonadotropic hypogonadism (HH) are important aspects of CHARGE syndrome in both boys and girls. Short stature is reported in 60&#x02013;72% of patients with CHARGE syndrome, although the underlying cause is often not well-documented.<xref rid="CIT0014" ref-type="bibr">14</xref>&#x02013;<xref rid="CIT0016" ref-type="bibr">16</xref> HH is also highly prevalent, and 60&#x02013;88% of patients with CHARGE syndrome do not achieve puberty spontaneously. Nonetheless, there are no syndrome-specific guidelines on how to induce puberty in this group of patients who frequently exhibit challenging behavior and therefore may respond differently to hormone replacement therapy.<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>&#x02013;<xref rid="CIT0019" ref-type="bibr">19</xref></p><p>A number of studies have now been published that describe aspects of growth and puberty in CHARGE syndrome. The aim of this review is to summarize what is currently known about growth in CHARGE syndrome in order to make recommendations for the multidisciplinary approach and identify what future studies are needed to develop evidence-based guidelines for growth and puberty surveillance in CHARGE syndrome.</p></sec><sec id="S0002"><title>Methods</title><p>
For this systematic review, we conducted a literature search on growth and puberty in CHARGE syndrome in PubMED using MeSH terms and in Embase using Emtree terms. We also searched on title and abstract based on keywords related to growth and puberty and included publications regarding <italic>CHD7</italic> and Kallmann syndrome because HH is also a feature of Kallmann syndrome and mutations in the <italic>CHD7</italic> gene may be found in these patients.<xref rid="CIT0020" ref-type="bibr">20</xref> Our search terms and selection process are described in <xref rid="F0001" ref-type="fig">Figure 1</xref>. We excluded all duplicate records and those that were not in English and selected possibly relevant records on title and abstract. The final selection was made after reading the complete publication (DD, GB). The references of the selected articles were checked for any relevant articles that might have been missed.<fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow chart of publication selection. Entry terms: CHARGE syndrome, CHARGE association, Hall Hittner syndrome, Hall Hittner association, growth, body size, weight, height, body mass, BMI, length, birth weight, head circumference, short stature, birth size, morphometry, anthropometry, puberty, hypogonadism, Kallmann, adolescent and adolescence. MeSH terms for PubMED search: CHARGE syndrome, Body weights and measures, growth and development, puberty, delayed puberty and hypogonadism. Emtree terms for Embase search: syndrome CHARGE, morphometry and growth, development and aging.</p><p><bold>Abbreviations:</bold> CHARGE, coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital hypoplasia, ear anomalies including hearing loss. BMI, body mass index.</p></caption><graphic content-type="print-only" xlink:href="JMDH-12-607-g0001"/></fig></p></sec><sec id="S0003"><title>Results</title><sec id="S0003-S2001"><title>Growth in CHARGE syndrome</title><p>
Of the studies we found, 22 specifically mentioned growth and 18 of these presented growth data in percentiles or SD values in relation to a reference population. These results are summarized in <xref rid="T0001" ref-type="table">Table 1</xref>. Below, we review the current knowledge about growth in the context of different phases of life.<table-wrap id="T0001" orientation="landscape" position="float"><label>Table 1</label><caption><p>Growth data from literature</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Author, year</th><th rowspan="1" colspan="1">Study type</th><th rowspan="1" colspan="1">Prenatal/at birth</th><th rowspan="1" colspan="1">0&#x02013;3&#x000a0;years</th><th rowspan="1" colspan="1">3&#x02013;12&#x000a0;years</th><th rowspan="1" colspan="1">12&#x02013;18&#x000a0;years</th><th rowspan="1" colspan="1">18+</th><th rowspan="1" colspan="1">No specified age group</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Aguiar-Oliveira, 2017<xref rid="CIT0022" ref-type="bibr">22</xref></td><td rowspan="1" colspan="1">Case-report</td><td rowspan="1" colspan="1">Born at term (40&#x000a0;weeks)<break/>US: normal intrauterine growth<break/>BL 46cm, BW 2.9kg, both below 3rd percentile</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Aramaki, 2006<xref rid="CIT0021" ref-type="bibr">21</xref></td><td rowspan="1" colspan="1">Cohort study.<break/>17 children with CHARGE syndrome and CHD7 mutation (5 mo&#x02013;18&#x000a0;yrs).</td><td rowspan="1" colspan="1">BL &#x00026; BW: SGA?</td><td rowspan="1" colspan="1">H range (n=5)<break/>-4.4/-5.6SD<break/>W range (n=5)<break/>-2.6/-5.9SD<break/>Age range<break/>5 mo&#x02013;2&#x000a0;y 6&#x000a0;mo</td><td rowspan="1" colspan="1">H range (n=8)<break/>-1.5/-6.0SD<break/>W range (n=8)<break/>-0.7/-4.7SD<break/>Age range<break/>3&#x000a0;y&#x02013;6&#x000a0;y 5&#x000a0;mo</td><td rowspan="1" colspan="1">H range (n=3)<break/>-2.9/-7.1SD<break/>W range (n=3)<break/>-1.5/-3.6SD<break/>Age range 12&#x000a0;y&#x02013;18&#x000a0;y</td><td rowspan="1" colspan="1">H (n=1) &#x02212;2.5SD<break/>W (n=1) &#x02212;0.7SD</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Asakura, 2008<xref rid="CIT0023" ref-type="bibr">23</xref></td><td rowspan="1" colspan="1">Cohort study.<break/>8 children with CHARGE syndrome and CHD7 mutation.</td><td rowspan="1" colspan="1">Average BL &#x02212;1.9SD</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">H&#x000a0;&#x0003c;&#x02212;2SD in all cases<break/>Age range<break/>0.9&#x02013;11.0&#x000a0;y<break/>1 patient 0.9&#x000a0;y; rest 5.8&#x02013;11.0&#x000a0;y</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Blake, 2005<xref rid="CIT0014" ref-type="bibr">14</xref></td><td rowspan="1" colspan="1">Cohort study. 30 adults and adolescents with CHARGE syndrome.</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male (n=5) mean H 167.5<break/>Female (n=6) mean H 161cm</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Blake, 1993<xref rid="CIT0024" ref-type="bibr">24</xref></td><td rowspan="1" colspan="1">Cohort study. 44 children 0.5&#x02013;18&#x000a0;y</td><td rowspan="1" colspan="1">Mean BW &#x00026; BL on or above 50th percentile</td><td rowspan="1" colspan="1">Mean W &#x00026; H for boys and girls &#x0003c;3rd percentile. Catch-up growth in preschool years</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Dauber, 2010<xref rid="CIT0025" ref-type="bibr">25</xref></td><td rowspan="1" colspan="1">Case report</td><td rowspan="1" colspan="1">BW&#x000a0; &#x0007e; 50th percentile<break/>BL 25th&#x02013;50th percentile</td><td rowspan="1" colspan="1">H&#x000a0;&#x0003c;5th percentile from 2&#x000a0;y</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">15&#x000a0;y<break/>H &#x02212;3.1SD<break/>W &#x02212;1.4SD</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">D&#x000f6;rr, 2015<xref rid="CIT0026" ref-type="bibr">26</xref></td><td rowspan="1" colspan="1">Cohort study.<break/>19 patients (9f; 10m)</td><td rowspan="1" colspan="1">Median BW &#x02212;0.78SD<break/>BL &#x02212;0.5SD</td><td rowspan="1" colspan="1">3&#x02013;4&#x000a0;weeks median H &#x02212;2.36<break/>1&#x000a0;y median H &#x02212;2.52SD<break/>Median BMI &#x02212;1.15SD</td><td rowspan="1" colspan="1">5&#x000a0;y median H &#x02212;2.8<break/>Median BMI &#x02212;0.15SD</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Forward, 2007<xref rid="CIT0031" ref-type="bibr">31</xref></td><td rowspan="1" colspan="1">Cohort study. 30 patients (15m;15f) 13&#x02013;34&#x000a0;y</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">H 30% 10th&#x02013;25th percentile; 56% &#x0003c;5th percentile. 11% overweight; 74% normal weight; 15% underweight.</td></tr><tr><td rowspan="1" colspan="1">Harvey, 1991<xref rid="CIT0027" ref-type="bibr">27</xref></td><td rowspan="1" colspan="1">Cohort study. 17 patients, 7 survivors</td><td rowspan="1" colspan="1">3/17 SGA</td><td rowspan="1" colspan="1">Failure to thrive in 7/7 patients. 4/7 catch-up growth after 1&#x02013;2&#x000a0;years.</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Husu, 2012<xref rid="CIT0015" ref-type="bibr">15</xref></td><td rowspan="1" colspan="1">Cohort study. 18 patients (15 growth data)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">H &#x02264; &#x02212;2.5SD in 9/15 (60%) of patients</td></tr><tr><td rowspan="1" colspan="1">Jain, 2011<xref rid="CIT0042" ref-type="bibr">42</xref></td><td rowspan="1" colspan="1">Case-report</td><td rowspan="1" colspan="1">Premature birth (25&#x000a0;weeks) BW 795 g</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">18&#x000a0;y H &#x02212;3.58SD</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Jongmans, 2006<xref rid="CIT0006" ref-type="bibr">6</xref></td><td rowspan="1" colspan="1">Cohort study. 2days&#x02013;40&#x000a0;years</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">63% (21/32) H &#x0003c;3rd percentile</td></tr><tr><td rowspan="1" colspan="1">Khadilkar, 1999<xref rid="CIT0030" ref-type="bibr">30</xref></td><td rowspan="1" colspan="1">Cohort study. 4 children with CHARGE (3M; 1F)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">H (n=1) &#x02212;3.0SD</td><td rowspan="1" colspan="1">H range (n=3)<break/>-2.7SD/-4.3SD</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Legendre, 2012<xref rid="CIT0029" ref-type="bibr">29</xref></td><td rowspan="1" colspan="1">Retrospective case series.<break/>40 fetuses with CHD7 mutation</td><td rowspan="1" colspan="1">No IUGR</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Legendre, 2017<xref rid="CIT0007" ref-type="bibr">7</xref></td><td rowspan="1" colspan="1">Cohort study. 119 patients with CHARGE syndrome (90% typical CHARGE)</td><td rowspan="1" colspan="1">Mean gestation at birth 36.6&#x000a0;weeks<break/>Mean BW &#x02212;0.6SD<break/>Mean BL &#x02212;1.3SD<break/>IUGR in 26% of cases</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mean H<break/>-1.7SD<break/>Mean W<break/>-0.9SD</td></tr><tr><td rowspan="1" colspan="1">Pinto, 2005<xref rid="CIT0018" ref-type="bibr">18</xref></td><td rowspan="1" colspan="1">Cohort study. 32 patients with CHARGE (20M; 12F)</td><td rowspan="1" colspan="1">34% SGA</td><td rowspan="1" colspan="1">Median H (n=25)<break/>-1.5SD at 1 y<break/>Median H (n=25)<break/>-1.5SD at 2 y</td><td rowspan="1" colspan="1">Median H (n=25)<break/>-2SD at 5&#x000a0;y<break/>Median H (n=9)<break/>-2.4SD</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Searle, 2005<xref rid="CIT0028" ref-type="bibr">28</xref></td><td rowspan="1" colspan="1">Case-report. m patient with CHARGE from birth to 33 y</td><td rowspan="1" colspan="1">Normal size at birth</td><td rowspan="1" colspan="1">11&#x000a0;months W &#x0003c;3rd percentile</td><td rowspan="1" colspan="1">3&#x000a0;y: W 5th percentile<break/>H 10th percentile</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Adult height 173.5&#x000a0;cm<break/>BMI 34.5</td></tr><tr><td rowspan="1" colspan="1">Shoji, 2011<xref rid="CIT0016" ref-type="bibr">16</xref></td><td rowspan="1" colspan="1">Cohort study.<break/>25 patients with CHARGE</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">H range (n=3)<break/>-4.2/-3.2SD<break/>W range (n=3)<break/>-4.2/-2.3SD</td><td rowspan="1" colspan="1">H range (n=12)<break/>-5.4/-0.2SD<break/>W range (n=10)<break/>-3.3/0SD</td><td rowspan="1" colspan="1">H range (n=5)<break/>-4.8/-2.5SD<break/>W range (n=5)<break/>-2.8/-0.2SD</td><td rowspan="1" colspan="1">H range (n=5)<break/>-8.7/-1SD<break/>W range (n=5)<break/>-5/0.1SD</td><td rowspan="1" colspan="1">Mean H in m (n=12)<break/>-3.04SD<break/>Mean H in f (n=10)<break/>-3.64SD</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Abbreviations:</bold> US, ultrasound; BL, birth length; BW, birth weight; H, height; W, weight; SGA, small for gestational age; y, year/s; mo, months; IUGR, intra uterine growth retardation; m, male; f, female; CHARGE, coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital hypoplasia, ear anomalies including hearing loss.</p></fn></table-wrap-foot></table-wrap>
</p><sec id="S0003-S2001-S3001"><title>Fetal growth</title><p>In a cohort of 119 children with CHARGE syndrome, the mean gestational age at birth was 36.6&#x000b1;2.2&#x000a0;weeks.<xref rid="CIT0007" ref-type="bibr">7</xref> In another small cohort, 16 out of 17 children were born at term.<xref rid="CIT0021" ref-type="bibr">21</xref> Birth weight and length were generally normal or slightly reduced when compared to a reference population.<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>&#x02013;<xref rid="CIT0028" ref-type="bibr">28</xref> However, a small proportion of children with CHARGE syndrome are small for their gestational age.<xref rid="CIT0021" ref-type="bibr">21</xref>&#x02013;<xref rid="CIT0023" ref-type="bibr">23</xref>,<xref rid="CIT0027" ref-type="bibr">27</xref> According to Legendre and Pinto, this is true for 26&#x02013;34% of children with CHARGE syndrome.<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref> In another study by Legendre et al that described the characteristics of 40 deceased fetuses with CHARGE syndrome, no intra-uterine growth retardation was found.<xref rid="CIT0029" ref-type="bibr">29</xref> This is remarkable considering that this group probably represents the more severely affected spectrum of CHARGE syndrome. Thus, the largest decrease in growth velocity happens the first period after birth.</p></sec><sec id="S0003-S2001-S3002"><title>Growth from 0&#x02013;3&#x000a0;years</title><p>All the published studies we found showed a sudden decrease in growth rate from early infancy onwards.<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0024" ref-type="bibr">24</xref>&#x02013;<xref rid="CIT0028" ref-type="bibr">28</xref>,<xref rid="CIT0030" ref-type="bibr">30</xref> In a study of 19 German children aged 0&#x02013;6&#x000a0;years, a sudden decrease in growth rate and body length was documented from as early as 4&#x000a0;weeks of age when compared to a reference population.<xref rid="CIT0026" ref-type="bibr">26</xref> Some authors have described catch-up growth in pre-school years,<xref rid="CIT0024" ref-type="bibr">24</xref>,<xref rid="CIT0027" ref-type="bibr">27</xref> while others have described persistently delayed growth with a height between &#x02212;2.36 and &#x02212;5.6 SD and no catch-up growth.<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0026" ref-type="bibr">26</xref>,<xref rid="CIT0030" ref-type="bibr">30</xref> In addition to short stature, weight is also frequently below average and BMI is low.<xref rid="CIT0026" ref-type="bibr">26</xref></p></sec><sec id="S0003-S2001-S3003"><title>Growth from 3&#x02013;12&#x000a0;years</title><p>During the early school years, short stature persists in children with CHARGE syndrome, with an average height between &#x02212;2 to &#x02212;3 SD below the reference population.<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0023" ref-type="bibr">23</xref>,<xref rid="CIT0026" ref-type="bibr">26</xref>,<xref rid="CIT0028" ref-type="bibr">28</xref>,<xref rid="CIT0030" ref-type="bibr">30</xref> In these years, the risk of developing scoliosis should warrant attention (see section Factors contributing to growth retardation).</p></sec><sec id="S0003-S2001-S3004"><title>Growth from 12&#x02013;18&#x000a0;years and later: growth from 12&#x02013;18&#x000a0;years and later</title><p>During the adolescent years, height remains significantly below average,<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0025" ref-type="bibr">25</xref> and the majority of children with CHARGE syndrome have absent or delayed puberty due to HH.<xref rid="CIT0017" ref-type="bibr">17</xref> These children will not undergo a pubertal growth spurt unless treated with hormone replacement therapy (HH is discussed in section Factors contributing to growth retardation).</p><p>Weight tends to increase in adolescence and adulthood, which poses a risk for the development of obesity, and there is some anecdotal evidence that older individuals with CHARGE syndrome are at risk for developing obesity.<xref rid="CIT0014" ref-type="bibr">14</xref>,<xref rid="CIT0028" ref-type="bibr">28</xref> However, other studies are less conclusive, indicating that weight is still below average.<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0025" ref-type="bibr">25</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref> In a study of 30 adolescents and adults with CHARGE syndrome, Forward et al found that 74% had normal weight, 15% were underweight and 11% were overweight.<xref rid="CIT0031" ref-type="bibr">31</xref></p></sec></sec><sec id="S0003-S2002"><title>Factors contributing to growth retardation</title><p>There are many different characteristics in CHARGE syndrome that may negatively influence growth, with feeding difficulties, cardiac malformations, frequent hospitalization and multiple surgeries being particularly important. In addition, endocrinological problems such as growth hormone deficiency, HH and hypothyroidism can negatively influence growth. Below we review the most common factors that may influence growth in CHARGE syndrome per age group.</p></sec><sec id="S0003-S2003"><title>0&#x02013;3&#x000a0;years of age</title><sec id="S0003-S2003-S3001"><title>Feeding difficulties</title><p>The prevalence of feeding difficulties in CHARGE syndrome is almost 100%. In addition, up to 92% of individuals with CHARGE syndrome have been tube fed at some point in their life.<xref rid="CIT0032" ref-type="bibr">32</xref> These numbers indicate that feeding difficulties are a very important issue in CHARGE syndrome. The decrease in growth rate in early infancy and the slow weight gain during the largest part of childhood strongly suggest that these feeding difficulties are an important factor in growth retardation.</p><p>While feeding difficulties can occur at any age, they probably influence growth most in early childhood. There are many different reasons why feeding is at risk in CHARGE syndrome. These include problems with chewing, sucking and swallowing. These issues are mainly due to cranial nerve dysfunction, but they are also influenced by hypotonia and anatomical variations of the facio-oral region, such as atresia of choanae and cleft lip and/or palate. A vascular ring can also impede food passing down through the esophagus. In addition, sensory problems such as hypersensitivity and anosmia can make eating or drinking uncomfortable or unpleasant. Aberrant feeding behavior, like pocketing food or unusual chewing or swallowing patterns are common in CHARGE syndrome.<xref rid="CIT0032" ref-type="bibr">32</xref>&#x02013;<xref rid="CIT0035" ref-type="bibr">35</xref></p><p>In addition to problems with ingestion, gastro-intestinal problems can also have a negative influence on feeding. Gastro-esophageal reflux is a common problem in CHARGE syndrome, and abdominal migraine and constipation can cause abdominal pain and reduced appetite.<xref rid="CIT0035" ref-type="bibr">35</xref></p></sec><sec id="S0003-S2003-S3002"><title>Critical illness, multiple surgeries and hospital admissions</title><p>Children with CHARGE syndrome often require many medical interventions and hospitalizations, particularly at a young age.<xref rid="CIT0036" ref-type="bibr">36</xref> Research among children from the general population in the pediatric intensive care unit and neonatal intensive care unit has shown that these children, especially infants, have an increased risk of malnourishment and growth retardation that is probably caused by a combination of increased metabolic state and feeding difficulties.<xref rid="CIT0037" ref-type="bibr">37</xref>,<xref rid="CIT0038" ref-type="bibr">38</xref></p></sec><sec id="S0003-S2003-S3003"><title>Cardiovascular malformations</title><p>Cardiovascular malformations are common in CHARGE syndrome, with 65&#x02013;92% of patients having a cardiovascular malformation. Many different types of malformations can occur, with the most prevalent being conotruncal defects, septal defects and atrioventricular septal defects.<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0039" ref-type="bibr">39</xref> As discussed above, a vascular ring can cause swallowing problems if it occludes the esophagus.<xref rid="CIT0033" ref-type="bibr">33</xref> Cardiovascular malformations are also associated with malnutrition and failure to thrive, probably due to a combination of a hypermetabolic state, inadequate caloric intake, feeding difficulties and gastro-intestinal problems.<xref rid="CIT0040" ref-type="bibr">40</xref> Of note, poor growth in children with cardiovascular malformations has been associated with poorer physical and neurodevelopmental outcomes.<xref rid="CIT0040" ref-type="bibr">40</xref>,<xref rid="CIT0041" ref-type="bibr">41</xref></p></sec></sec><sec id="S0003-S2004"><title>4&#x02013;12&#x000a0;years of age</title><sec id="S0003-S2004-S3001"><title>Skeletal abnormalities</title><p>Scoliosis is a common problem in CHARGE syndrome due to decreased muscle tone. In a survey of 31 older patients with CHARGE syndrome, 19 were reported to have scoliosis with variable severity, and the mean age at which scoliosis was diagnosed was 6.25&#x000a0;years.<xref rid="CIT0014" ref-type="bibr">14</xref> The prevalence of scoliosis was also high in another cohort of older individuals with CHARGE syndrome, where Forward et al reported a prevalence of 50% in a cohort of individuals aged 13&#x02013;34&#x000a0;years.<xref rid="CIT0031" ref-type="bibr">31</xref> Scoliosis can negatively influence height and usually deteriorates with age. Therefore, when considering growth hormone treatment, a physical examination should be conducted with special attention paid to the presence of scoliosis because of the risk of deterioration with increased growth rate.</p></sec><sec id="S0003-S2004-S3002"><title>Growth hormone deficiency, hypothyroidism and hypoparathyroidism</title><p>Because most individuals with CHARGE syndrome have short stature and HH, other pituitary functions in CHARGE syndrome have been frequently studied. Combined pituitary dysfunction is uncommon in CHARGE syndrome. Some authors have reported hypothyroidism among patients with CHARGE syndrome with a prevalence of 12&#x02013;18%.<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0023" ref-type="bibr">23</xref> However, Pinto et al did not report hypothyroidism among 26 patients tested for abnormal levels of TSH and free T4.<xref rid="CIT0018" ref-type="bibr">18</xref> Incidental cases of hypoparathyroidism have been found in patients with typical and atypical CHARGE syndrome.<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0042" ref-type="bibr">42</xref> Given their low prevalence, the risk of poor growth due to hypothyroidism or hypoparathyroidism in CHARGE syndrome is probably small.</p><p>Growth hormone deficiency is more common in CHARGE syndrome, being reported with a frequency of 12&#x02013;34% in several studies.<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0023" ref-type="bibr">23</xref> Growth hormone therapy may be a safe and effective way to increase growth in patients with CHARGE syndrome suffering from growth hormone deficiency, although no randomized controlled trials are available. In a cohort study of 16 patients with CHARGE syndrome who were registered in the Pfizer international growth database for patients treated with growth hormone, growth velocity increased after growth hormone supplementation and adverse events were generally mild, although one patient with kyphoscoliosis was reported.<xref rid="CIT0043" ref-type="bibr">43</xref> Therefore, when considering growth hormone treatment, a physical examination should be conducted with special attention to the possible presence of scoliosis due to its increased prevalence in CHARGE syndrome and the possible risk of deterioration with increased growth velocity.</p></sec></sec><sec id="S0003-S2005"><title>From 12&#x02013;18&#x000a0;years</title><sec id="S0003-S2005-S3001"><title>Hypogonadotropic hypogonadism</title><p>Delayed or absent puberty due to HH is common in CHARGE syndrome. The prevalence of HH is estimated to be between 60% and 88%, with HH being more common in boys. In boys, cryptorchidism and micropenis may be signs of HH, while girls usually have normally developed external genitalia. However, in a minority of cases, girls present with hypoplastic labia at birth. Other genitourinary malformations related to HH in girls with CHARGE syndrome are rare.<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>&#x02013;<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0044" ref-type="bibr">44</xref></p><p>HH can be diagnosed in the first 6&#x000a0;months of life or at pubertal age by the detection of low blood levels of luteinising hormone and follicle stimulating hormone, together with low levels of testosterone in boys and estradiol in girls. Due to a strong correlation between olfactory function and HH in CHARGE syndrome, the presence of anosmia is a strong indicator of HH.<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref> This co-occurrence of anosmia and HH also occurs in Kallmann syndrome, which suggests an overlap between both syndromes. Several studies have shown that approximately 6% of patients previously diagnosed with Kallmann syndrome have a <italic>CHD7</italic> gene mutation, and most of these patients appeared to have more CHARGE syndrome characteristics after close examination.<xref rid="CIT0020" ref-type="bibr">20</xref>,<xref rid="CIT0045" ref-type="bibr">45</xref>&#x02013;<xref rid="CIT0047" ref-type="bibr">47</xref></p><p>HH can be treated by hormone replacement therapy, either with testosterone or human chorionic gonadotropin (which stimulates the production of testosterone in the testis) in boys and estrogens in girls.<xref rid="CIT0048" ref-type="bibr">48</xref> Currently, there is no evidence-based data on what is the preferred therapy for male HH in CHARGE syndrome.</p><p>HH may contribute to a short stature because patients with HH lack a pubertal growth spurt. When hormone replacement therapy is not started, growth will slowly continue through adolescent years due to delayed epiphyseal closure.<xref rid="CIT0049" ref-type="bibr">49</xref> This may lead to a taller final height, but usually results in characteristic body proportions with relatively long limbs and a short trunk.</p><p>Another important complication of delayed puberty is osteoporosis. The risk for osteoporosis is probably further increased in patients with CHARGE syndrome due to feeding difficulties and a reduced level of physical activity.<xref rid="CIT0031" ref-type="bibr">31</xref> Thus, in addition to inducing the development of secondary sexual physical characteristics, hormone replacement therapy may be important to both prevent osteoporosis and improve growth.</p></sec></sec><sec id="S0003-S2006"><title>Recommendations for multidisciplinary care</title><p>The need for a multidisciplinary approach to the medical problems in children with CHARGE syndrome was already being discussed in 1990 when Blake et al studied 50 patients with CHARGE association, the majority of whom underwent at least one major surgical intervention.<xref rid="CIT0050" ref-type="bibr">50</xref> The authors concluded that outcome could be improved by collaboration between specialist surgical teams and suggested that a pediatric Ear Nose Throat (ENT)-specialist and a general or community pediatrician would be the most appropriate coordinators of the long-term multidisciplinary management of these patients. Since then, only a few articles have been published on the multidisciplinary care of children with CHARGE syndrome,<xref rid="CIT0051" ref-type="bibr">51</xref> which is remarkable given that the expanding phenotype of CHARGE syndrome<xref rid="CIT0044" ref-type="bibr">44</xref> has led to an increased number of medical disciplines becoming involved in the care of children with CHARGE syndrome.</p><p>The healthcare transition from pediatrics into adult care systems requires special attention. In the last decades, there has been an increased awareness of the importance of healthcare transition into adulthood of patients with pediatric-onset conditions.<xref rid="CIT0052" ref-type="bibr">52</xref> However, effective transition remains challenging, particularly for patients with rare and complex conditions.<xref rid="CIT0053" ref-type="bibr">53</xref> In addition, many studies have shown that people with intellectual disabilities experience health disparities, partly due to limited access to care.<xref rid="CIT0054" ref-type="bibr">54</xref>,<xref rid="CIT0055" ref-type="bibr">55</xref></p><p>Inefficient and siloed systems, lack of resources, lack of communication and collaboration between professionals, and a lack of knowledge among adult health care professionals about pediatric-onset conditions, rare diseases and intellectual disability have been recognized as barriers to effective transition of care and targets for improvement of transition.<xref rid="CIT0056" ref-type="bibr">56</xref></p><p>There are many different ways to organize healthcare transition. A review by Gabriel et al showed that different types of transition strategies have proved to be successful with regard to population health, consumer experience and utilization of care as long as they provide a systematic approach.<xref rid="CIT0057" ref-type="bibr">57</xref> Thus, depending on the local situation, effective health care transition can be modelled in several ways. However, the following aspects should be incorporated: the transition should be started in a timely manner, it should involve a broad view on care (such as attention to issues like fertility and legal representation), it should involve extensive communication between the pediatric team and the adult team and there should be a coordinating care provider. The American Academy of Pediatrics advises to start planning healthcare transition from 12&#x02013;14&#x000a0;years of age.<xref rid="CIT0052" ref-type="bibr">52</xref> In CHARGE syndrome, multidisciplinary CHARGE clinics can play an important role in this transition, either by providing adult care themselves or by educating local healthcare providers about CHARGE syndrome and patient-specific topics. During childhood, a pediatrician is usually the coordinating health care provider. In adulthood, this role should be transferred to a physician working with adults, preferably someone with expertise on complex disorders.<xref rid="CIT0058" ref-type="bibr">58</xref>,<xref rid="CIT0059" ref-type="bibr">59</xref></p><p>Growth monitoring is considered part of standard pediatric care. It is important for identifying children who are at risk of undernutrition or have a medical condition that affects growth, and appears to be cost-effective.<xref rid="CIT0060" ref-type="bibr">60</xref> There is some evidence that retarded growth in early childhood is associated with worse neurodevelopmental outcomes and might also negatively influence adult health parameters. However, this research is complicated by the presence of confounders.<xref rid="CIT0061" ref-type="bibr">61</xref>,<xref rid="CIT0062" ref-type="bibr">62</xref> Research among children with congenital heart disease showed that low weight for age was associated with prolonged hospitalization, a higher rate of infections and a higher mortality rate after cardiac surgery.<xref rid="CIT0040" ref-type="bibr">40</xref>,<xref rid="CIT0041" ref-type="bibr">41</xref> The largest decrease in growth velocity in CHARGE can be seen in the first years of life. This decrease, which occurs during the most critical period of life from a medical perspective, suggests that at least part of this early growth retardation is influenced by chronic illness, multiple surgeries and feeding difficulties. This provides a challenge for professionals: How can we limit the number of hospital visits and medical procedures and optimize nutritional status? However, there are other health problems common in CHARGE syndrome that can also influence growth. Given the complex nature of the syndrome and the co-occurrence of these problems, a multi-disciplinary approach is essential. In <xref rid="T0002" ref-type="table">Table 2</xref> we summarize the most important problems and which professionals we suggest should be consulted.<table-wrap id="T0002" orientation="landscape" position="float"><label>Table 2</label><caption><p>Expert-based advice for multidisciplinary approach/guidance of medical problems in CHARGE syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Growth-related issues</th><th rowspan="1" colspan="1">0&#x02013;3&#x000a0;years</th><th rowspan="1" colspan="1">4&#x02013;12&#x000a0;years</th><th rowspan="1" colspan="1">13&#x02013;17&#x000a0;years</th><th rowspan="1" colspan="1">18+</th><th rowspan="1" colspan="1">Professionals involved</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Monitoring of growth</td><td rowspan="1" colspan="1">Height, weight, head circumference</td><td rowspan="1" colspan="1">Height, weight</td><td rowspan="1" colspan="1">Height, weight</td><td rowspan="1" colspan="1">Weight</td><td rowspan="1" colspan="1">Pediatrician<break/>General practitioner</td></tr><tr><td colspan="6" rowspan="1">Feeding difficulties</td></tr><tr><td rowspan="1" colspan="1">Problems with sucking, chewing or swallowing</td><td rowspan="1" colspan="1">Choanal atresia<break/>Cleft lip/palate<break/>Cranial nerve abnormalities<break/>Vascular ring</td><td rowspan="1" colspan="1">Cranial nerve abnormalities<break/>Vascular ring<break/>Dental problems</td><td rowspan="1" colspan="1">Cranial nerve abnormalities<break/>Vascular ring<break/>Dental problems</td><td rowspan="1" colspan="1">Cranial nerve abnormalities<break/>Dental problems</td><td rowspan="1" colspan="1">Speech and language therapist<break/>Pediatrician/(pediatric) neurologist<break/>Ear nose throat specialist<break/>Dentist<break/>Plastic surgeon<break/>(Pediatric) cardiologist (vascular ring)</td></tr><tr><td rowspan="1" colspan="1">Aberrant feeding behavior</td><td rowspan="1" colspan="1">Functional, sensory and psychological evaluation.</td><td rowspan="1" colspan="1">Functional, sensory and psychological evaluation.<break/>Think of: Sensory problems, intellectual disability, feeding experiences in the past.</td><td rowspan="1" colspan="1">Functional, sensory and psychological evaluation.</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Speech and language therapist<break/>Pediatrician<break/>Psychologist<break/>Intellectual disability physician (Netherlands)</td></tr><tr><td rowspan="1" colspan="1">Gastro-intestinal problems</td><td rowspan="1" colspan="1">Evaluation with special attention to: reflux, constipation, abdominal migraine.</td><td rowspan="1" colspan="1">Evaluation with special attention to: reflux, constipation, abdominal migraine.</td><td rowspan="1" colspan="1">Evaluation with special attention to: reflux, constipation, abdominal migraine.</td><td rowspan="1" colspan="1">Evaluation with special attention to: reflux, constipation, abdominal migraine.</td><td rowspan="1" colspan="1">Pediatrician/(pediatric) gastroenterologist<break/>Intellectual disability physician (Netherlands)</td></tr><tr><td colspan="6" rowspan="1">Chronic/critical disease</td></tr><tr><td rowspan="1" colspan="1">Cardiovascular problems</td><td rowspan="1" colspan="1">Combine surgeries and hospital admissions.<break/>Consider enriched diet/tube feeding.</td><td rowspan="1" colspan="1">Combine surgeries and hospital admissions.<break/>Consider enriched diet/tube feeding.</td><td rowspan="1" colspan="1">Combine surgeries and hospital admissions.<break/>Consider enriched diet/tube feeding.</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Pediatric cardiologist<break/>Pediatrician<break/>Dietician</td></tr><tr><td rowspan="1" colspan="1">Multiple surgeries and/or hospital admissions</td><td rowspan="1" colspan="1">Combine surgeries and hospital admissions.<break/>Consider enriched diet/tube feeding.</td><td rowspan="1" colspan="1">Combine surgeries and hospital admissions.<break/>Consider enriched diet/tube feeding.</td><td rowspan="1" colspan="1">Combine surgeries and hospital admissions.<break/>Consider enriched diet/tube feeding.</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Pediatrician<break/>Speech and language therapist<break/>Dietician</td></tr><tr><td colspan="6" rowspan="1">Orthopedic problems</td></tr><tr><td rowspan="1" colspan="1">Scoliosis</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Physical examination of spine.<break/>Radiologic evaluation.</td><td rowspan="1" colspan="1">Physical examination of spine.<break/>Radiologic evaluation.</td><td rowspan="1" colspan="1">Physical examination of spine.<break/>Radiologic evaluation.</td><td rowspan="1" colspan="1">Orthopedic surgeon<break/>Rehabilitation specialist</td></tr><tr><td colspan="6" rowspan="1">Endocrinological problems</td></tr><tr><td rowspan="1" colspan="1">Hypogonadotropic hypogonadism</td><td rowspan="1" colspan="1">Before 6&#x000a0;months of age: LH and FSH testing.</td><td rowspan="1" colspan="1">Smell test, LH, FSH, estrogen/testosterone testing (from &#x000b1;11&#x000a0;years of age).</td><td rowspan="1" colspan="1">Smell test, LH, FSH, estrogen/testosterone testing.<break/>Start hormone replacement therapy.</td><td rowspan="1" colspan="1">Continue hormone replacement therapy.</td><td rowspan="1" colspan="1">(Pediatric) endocrinologist</td></tr><tr><td rowspan="1" colspan="1">Hypothyroidism, hypoparathyroidism</td><td rowspan="1" colspan="1">Test when symptoms</td><td rowspan="1" colspan="1">Test when symptoms</td><td rowspan="1" colspan="1">Test when symptoms</td><td rowspan="1" colspan="1">Test when symptoms</td><td rowspan="1" colspan="1">Pediatrician/(pediatric) endocrinologist</td></tr><tr><td rowspan="1" colspan="1">Growth hormone deficiency</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Diagnostic tests for GH deficiency. Check for scoliosis.</td><td rowspan="1" colspan="1">Diagnostic tests for GH deficiency. Check for scoliosis.</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p><bold>Abbreviations:</bold>&#x000a0;CHARGE, coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital hypoplasia, ear anomalies including hearing loss; LH, luteinizing hormone; FSH, follicle stimulating hormone; GH, growth hormone.</p></fn></table-wrap-foot></table-wrap>
</p><p>Growth monitoring and health follow-up is preferably done by a pediatrician who has regular contact with the parents and who can decide when consultation with other professionals is necessary. A useful guideline and checklist was provided by Trider et al and supplemented with radiological guidelines by de Geus et al.<xref rid="CIT0063" ref-type="bibr">63</xref>,<xref rid="CIT0064" ref-type="bibr">64</xref> The discussion below provides more information with regard to specific growth-related issues.</p><sec id="S0003-S2006-S3001"><title>Feeding difficulties</title><p>At birth, children with CHARGE syndrome should be checked for choanal atresia by an ENT-specialist. Orofacial anomalies that require surgery, such as choanal atresia and cleft lip and/or palate, can be treated by an ENT specialist or plastic surgeon.<xref rid="CIT0063" ref-type="bibr">63</xref> When feeding difficulties are present, a speech therapist should be consulted for feeding analysis.<xref rid="CIT0063" ref-type="bibr">63</xref> Based on the nature of the problems, other professionals can be involved (see <xref rid="T0002" ref-type="table">Table 2</xref>). Blake and Hudson have written a useful review of feeding difficulties in CHARGE syndrome that includes practical advice for specific problems.<xref rid="CIT0033" ref-type="bibr">33</xref></p></sec><sec id="S0003-S2006-S3002"><title>Chronic or critical illness</title><p>At birth, all children with CHARGE syndrome should be screened for cardiovascular malformations, including a vascular ring, by means of a cardiac ultrasound and chest X-ray.<xref rid="CIT0063" ref-type="bibr">63</xref> When cardiovascular malformations are present, the child has to be referred to a pediatric cardiologist. The number of hospital admissions and anesthesias should be limited as much as possible. While in hospital, and before and after surgical intervention, extra attention should be paid to possible feeding difficulties and undernutrition. A dietician and speech therapist can help to improve feeding and nutritional status.<xref rid="CIT0040" ref-type="bibr">40</xref></p></sec><sec id="S0003-S2006-S3003"><title>Endocrine issues</title><p>Given the possibility of diagnosing HH during the so-called mini-puberty of infancy, a pediatric endocrinologist should be consulted in the first weeks or months of life and then again when the patient is reaching pubertal age or when growth hormone deficiency is suspected. Evaluation for hypothyroidism and hypoparathyroidism is only necessary if there are clinical signs or symptoms.</p></sec></sec></sec><sec id="S0004"><title>Conclusion</title><p>Growth retardation and short stature are present in the majority of individuals with CHARGE syndrome. Height and weight remain low in CHARGE children in all age groups, and adults typically have short stature. However, the largest decrease in growth velocity occurs in the first years of life. Given the broad spectrum of condition-related factors that might influence growth retardation, this complex problem requires a multidisciplinary approach towards diagnostics and treatment.</p><sec id="S0004-S2001"><title>Strengths and limitations of this study and recommendations for further research</title><p>In this review we systematically searched for previously published growth data to present the most extensive overview of growth data published thus far. However, because of the different ways of reporting growth data in the different studies and the low patient numbers per study, it was only possible to get a general overview of growth in CHARGE syndrome. Moreover, interpretation of body weight data is difficult because of the generally short stature. To be truly applicable in daily clinical practice, systematic collection of growth data and construction of CHARGE-syndrome-specific growth charts is necessary.</p><p>We have also described many factors that can negatively influence growth in CHARGE syndrome. However, no studies in children with CHARGE syndrome have proven that there is a statistically significant correlation between these conditions and growth retardation. The recommendations we make regarding interventions to improve care are therefore based on expert opinions. An extensive growth study with an analysis of the factors that influence growth would allow us to gain more insight into growth-related problems in CHARGE syndrome. For example, it would be interesting to know whether there is an intrinsic <italic>CHD7</italic> gene haploinsufficiency-effect on growth. Of the studies in this review, only Aramaki et al and Shoji et al described patients in sufficient detail to make it possible to compare their growth to their genotype.<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref> Dauber et al also presents one patient with a missense mutation and describes the growth characteristics of this patient.<xref rid="CIT0025" ref-type="bibr">25</xref></p><p>Aramaki and Shoji described 12 patients with a nonsense mutation, 13 patients with a frameshift mutation, 6 patients with a splice site mutation and 3 patients with a deletion.<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref> In this small cohort, we could not find a correlation between these different mutation types and growth. Due to the fact that we only had growth data for one patient with a missense mutation, we could not look into the effect of truncating vs non-truncating mutations on growth. In addition, some studies describe familial cases with CHARGE syndrome or cases of unrelated patients with identical CHD7 gene variants. The effect of identical gene variants on growth appears to be variable, which is in line with the wide variation in other characteristics of CHARGE syndrome observed in patients with identical gene mutations.<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0012" ref-type="bibr">12</xref>,<xref rid="CIT0065" ref-type="bibr">65</xref>&#x02013;<xref rid="CIT0067" ref-type="bibr">67</xref></p><p>Finally, knowledge about the risks and benefits of growth hormone therapy and hormone replacement therapy for HH in CHARGE syndrome remains limited. More research is needed to be able to make an evidence-based guideline on those therapies.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Nicole Corsten-Janssen for reviewing and Kate McIntyre for editing the manuscript.</p><p>This publication was made possible with funding from SBOH, opleiding arts verstandelijk gehandicapten and stichting vrienden Beatrix kinderziekenhuis.</p></ack><sec id="S0005" sec-type="COI-statement"><title>Disclosure</title><p>The authors report no conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Janssen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bergman</surname>
<given-names>JEH</given-names></string-name>, <string-name><surname>Swertz</surname>
<given-names>MA</given-names></string-name>, et al. <article-title>Mutation update on the CHD7 gene involved in CHARGE syndrome</article-title>. <source><italic toggle="yes">Hum Mutat</italic></source>. <year>2012</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1149</fpage>&#x02013;<lpage>1160</lpage>. doi:<pub-id pub-id-type="doi">10.1002/humu.22086</pub-id><pub-id pub-id-type="pmid">22461308</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Pagon</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>JM</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Zonana</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yong</surname>
<given-names>SL</given-names></string-name>. <article-title>Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association</article-title>. <source><italic toggle="yes">J Pediatr</italic></source>. <year>1981</year>;<volume>99</volume>(<issue>2</issue>):<fpage>223</fpage>&#x02013;<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0022-3476(81)80454-4</pub-id><pub-id pub-id-type="pmid">6166737</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Davenport</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>BD</given-names></string-name>, et al. <article-title>CHARGE association: an update and review for the primary pediatrician</article-title>. <source><italic toggle="yes">Clin Pediatr (Phila)</italic></source>. <year>1998</year>;<volume>37</volume>(<issue>3</issue>):<fpage>159</fpage>&#x02013;<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1177/000992289803700302</pub-id><pub-id pub-id-type="pmid">9545604</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Verloes</surname>
<given-names>A</given-names></string-name>. <article-title>Updated diagnostic criteria for CHARGE syndrome: a proposal</article-title>. <source><italic toggle="yes">Am J Med Genet</italic></source>. <year>2005</year>;<volume>133A</volume>(<issue>3</issue>):<fpage>306</fpage>&#x02013;<lpage>308</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.30559</pub-id><pub-id pub-id-type="pmid">15666308</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Vissers</surname>
<given-names>LELM</given-names></string-name>, <string-name><surname>van Ravenswaaij</surname>
<given-names>CMA</given-names></string-name>, <string-name><surname>Admiraal</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Mutations in a new member of the chromodomain gene family cause CHARGE syndrome</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2004</year>;<volume>36</volume>(<issue>9</issue>):<fpage>955</fpage>&#x02013;<lpage>957</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1407</pub-id><pub-id pub-id-type="pmid">15300250</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Jongmans</surname>
<given-names>MCJ</given-names></string-name>, <string-name><surname>Admiraal</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>van der Donk</surname>
<given-names>KP</given-names></string-name>, et al. <article-title>CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene</article-title>. <source><italic toggle="yes">J Med Genet</italic></source>. <year>2006</year>;<volume>43</volume>(<issue>4</issue>):<fpage>306</fpage>&#x02013;<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.2005.036061</pub-id><pub-id pub-id-type="pmid">16155193</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Legendre</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Abadie</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Attie-Bitach</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Phenotype and genotype analysis of a French cohort of 119 patients with CHARGE syndrome</article-title>. <source><italic toggle="yes">Am J Med Genet C Semin Med Genet</italic></source>. <year>2017</year>;<volume>175</volume>(<issue>4</issue>):<fpage>417</fpage>&#x02013;<lpage>430</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.31591</pub-id><pub-id pub-id-type="pmid">29178447</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Jongmans</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>van Ravenswaaij-Arts</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Pitteloud</surname>
<given-names>N</given-names></string-name>, et al. <article-title>CHD7 mutations in patients initially diagnosed with Kallmann syndrome&#x02013;the clinical overlap with CHARGE syndrome</article-title>. <source><italic toggle="yes">Clin Genet</italic></source>. <year>2009</year>;<volume>75</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.01107.x</pub-id><pub-id pub-id-type="pmid">19021638</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Marcos</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sarfati</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Leroy</surname>
<given-names>C</given-names></string-name>, et al. <article-title>The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2014</year>;<volume>99</volume>(<issue>10</issue>):<fpage>2138</fpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2014-2110</pub-id><pub-id pub-id-type="pmid">24606104</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Bergman</surname>
<given-names>JEH</given-names></string-name>, <string-name><surname>Janssen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>van der Sloot</surname>
<given-names>AM</given-names></string-name>, et al. <article-title>A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome</article-title>. <source><italic toggle="yes">Hum Mutat</italic></source>. <year>2012</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1251</fpage>&#x02013;<lpage>1260</lpage>. doi:<pub-id pub-id-type="doi">10.1002/humu.22106</pub-id><pub-id pub-id-type="pmid">22539353</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Lalani</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Safiullah</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Fernbach</surname>
<given-names>SD</given-names></string-name>, et al. <article-title>Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation</article-title>. <source><italic toggle="yes">Am J Hum Genet</italic></source>. <year>2006</year>;<volume>78</volume>(<issue>2</issue>):<fpage>303</fpage>&#x02013;<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1086/500273</pub-id><pub-id pub-id-type="pmid">16400610</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Jongmans</surname>
<given-names>MCJ</given-names></string-name>, <string-name><surname>Hoefsloot</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>van der Donk</surname>
<given-names>KP</given-names></string-name>, et al. <article-title>Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability</article-title>. <source><italic toggle="yes">Am J Med Genet A</italic></source>. <year>2008</year>;<volume>146A</volume>(<issue>1</issue>):<fpage>43</fpage>&#x02013;<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.31921</pub-id><pub-id pub-id-type="pmid">18074359</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Hale</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Niederriter</surname>
<given-names>AN</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>DM</given-names></string-name>. <article-title>Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria</article-title>. <source><italic toggle="yes">Am J Med Genet A</italic></source>. <year>2016</year>;<volume>170A</volume>(<issue>2</issue>):<fpage>344</fpage>&#x02013;<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.37435</pub-id><pub-id pub-id-type="pmid">26590800</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Salem-Hartshorne</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Daoud</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Gradstein</surname>
<given-names>J</given-names></string-name>. <article-title>Adolescent and adult issues in CHARGE syndrome</article-title>. <source><italic toggle="yes">Clin Pediatr (Phila)</italic></source>. <year>2005</year>;<volume>44</volume>(<issue>2</issue>):<fpage>151</fpage>&#x02013;<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1177/000992280504400207</pub-id><pub-id pub-id-type="pmid">15735833</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Husu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hove</surname>
<given-names>HD</given-names></string-name>, <string-name><surname>Farholt</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome</article-title>. <source><italic toggle="yes">Clin Genet</italic></source>. <year>2013</year>;<volume>83</volume>(<issue>2</issue>):<fpage>125</fpage>&#x02013;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1399-0004.2012.01884.x</pub-id><pub-id pub-id-type="pmid">22462537</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Shoji</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ida</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Etani</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Endocrinological characteristics of 25 Japanese patients with CHARGE syndrome</article-title>. <source><italic toggle="yes">Clin Pediat Endocrinol</italic></source>. <year>2014</year>;<volume>23</volume>(<issue>2</issue>):<fpage>45</fpage>&#x02013;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1297/cpe.23.45</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Bergman</surname>
<given-names>JEH</given-names></string-name>, <string-name><surname>Bocca</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Hoefsloot</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Meiners</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>van Ravenswaaij-Arts</surname>
<given-names>CMA</given-names></string-name>. <article-title>Anosmia predicts hypogonadotropic hypogonadism in CHARGE syndrome</article-title>. <source><italic toggle="yes">J Pediatr</italic></source>. <year>2011</year>;<volume>158</volume>(<issue>3</issue>):<fpage>474</fpage>&#x02013;<lpage>479</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.08.032</pub-id><pub-id pub-id-type="pmid">20884005</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Pinto</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Abadie</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mesnage</surname>
<given-names>R</given-names></string-name>, et al. <article-title>CHARGE Syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2005</year>;<volume>90</volume>(<issue>10</issue>):<fpage>5621</fpage>&#x02013;<lpage>5626</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2004-2474</pub-id><pub-id pub-id-type="pmid">16030162</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Hartshorne</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Stratton</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Madhavan-Brown</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schmittel</surname>
<given-names>MC</given-names></string-name>. <article-title>Behavior in CHARGE syndrome</article-title>. <source><italic toggle="yes">Am J Med Genet C Semin Med Genet</italic></source>. <year>2017</year>;<volume>175</volume>(<issue>4</issue>):<fpage>431</fpage>&#x02013;<lpage>438</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.31588</pub-id><pub-id pub-id-type="pmid">29082623</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Bergman</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>de Ronde</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Jongmans</surname>
<given-names>MC</given-names></string-name>, et al. <article-title>The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2012</year>;<volume>97</volume>(<issue>5</issue>):<fpage>858</fpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2011-2652</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Aramaki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Udaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kosaki</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Phenotypic spectrum of CHARGE syndrome with CHD7 mutations</article-title>. <source><italic toggle="yes">J Pediatr</italic></source>. <year>2006</year>;<volume>148</volume>(<issue>3</issue>):<fpage>410</fpage>&#x02013;<lpage>414</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2005.10.044</pub-id><pub-id pub-id-type="pmid">16615981</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Aguiar-Oliveira</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Davalos</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Campos</surname>
<given-names>VC</given-names></string-name>, <string-name><surname>Oliveira Neto</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Marinho</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Oliveira</surname>
<given-names>CRP</given-names></string-name>. <article-title>Hypothalamic abnormalities: growth failure due to defects of the GHRH receptor</article-title>. <source><italic toggle="yes">Growth Horm IGF Res</italic></source>. <year>2018</year>;<volume>38</volume>:<fpage>14</fpage>&#x02013;<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ghir.2017.12.011</pub-id><pub-id pub-id-type="pmid">29277338</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Asakura</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Toyota</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Muroya</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Endocrine and radiological studies in patients with molecularly confirmed CHARGE syndrome</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2008</year>;<volume>93</volume>(<issue>3</issue>):<fpage>920</fpage>&#x02013;<lpage>924</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2007-1419</pub-id><pub-id pub-id-type="pmid">18089695</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kirk</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ur</surname>
<given-names>E</given-names></string-name>. <article-title>Growth in CHARGE association</article-title>. <source><italic toggle="yes">Arch Dis Child</italic></source>. <year>1993</year>;<volume>68</volume>(<issue>4</issue>):<fpage>508</fpage>&#x02013;<lpage>509</lpage>. doi:<pub-id pub-id-type="doi">10.1136/adc.68.4.508</pub-id><pub-id pub-id-type="pmid">8503679</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Dauber</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hirschhorn</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Picker</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Maher</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Milunsky</surname>
<given-names>A</given-names></string-name>. <article-title>Delayed puberty due to a novel mutation in CHD7 causing CHARGE syndrome</article-title>. <source><italic toggle="yes">Pediatrics</italic></source>. <year>2010</year>;<volume>126</volume>(<issue>6</issue>):<fpage>1594</fpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2010-0164</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>D&#x000f6;rr</surname>
<given-names>HG</given-names></string-name>, <string-name><surname>Madeja</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Junghans</surname>
<given-names>C</given-names></string-name>. <article-title>Spontaneous postnatal growth is reduced in children with CHARGE syndrome</article-title>. <source><italic toggle="yes">Acta Paediatr Int J Paediatr</italic></source>. <year>2015</year>;<volume>104</volume>(<issue>7</issue>):<fpage>e318</fpage>. doi:<pub-id pub-id-type="doi">10.1111/apa.12980</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Harvey</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Leaper</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Bankier</surname>
<given-names>A</given-names></string-name>. <article-title>CHARGE association: clinical manifestations and developmental outcome</article-title>. <source><italic toggle="yes">Am J Med Genet</italic></source>. <year>1991</year>;<volume>39</volume>(<issue>1</issue>):<fpage>48</fpage>&#x02013;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.1320390112</pub-id><pub-id pub-id-type="pmid">1867265</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Searle</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>JM</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Prasad</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>. <article-title>CHARGE syndrome from birth to adulthood: an individual reported on from 0 to 33 years</article-title>. <source><italic toggle="yes">Am J Med Genet A</italic></source>. <year>2005</year>;<volume>133A</volume>(<issue>3</issue>):<fpage>344</fpage>&#x02013;<lpage>349</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.30565</pub-id><pub-id pub-id-type="pmid">15637714</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Legendre</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gonzales</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Goudefroye</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Antenatal spectrum of CHARGE syndrome in 40 fetuses with CHD7 mutations</article-title>. <source><italic toggle="yes">J Med Genet</italic></source>. <year>2012</year>;<volume>49</volume>(<issue>11</issue>):<fpage>698</fpage>&#x02013;<lpage>707</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmedgenet-2012-100926</pub-id><pub-id pub-id-type="pmid">23024289</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Khadilkar</surname>
<given-names>VV</given-names></string-name>, <string-name><surname>Cameron</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Stanhope</surname>
<given-names>R</given-names></string-name>. <article-title>Growth failure and pituitary function in CHARGE and VATER associations</article-title>. <source><italic toggle="yes">Arch Dis Child</italic></source>. <year>1999</year>;<volume>80</volume>(<issue>2</issue>):<fpage>167</fpage>&#x02013;<lpage>170</lpage>. doi:<pub-id pub-id-type="doi">10.1136/adc.80.2.167</pub-id><pub-id pub-id-type="pmid">10325734</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Forward</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Cummings</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>. <article-title>Risk factors for poor bone health in adolescents and adults with CHARGE syndrome</article-title>. <source><italic toggle="yes">Am J Med Genet A</italic></source>. <year>2007</year>;<volume>143A</volume>(<issue>8</issue>):<fpage>839</fpage>&#x02013;<lpage>845</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.31670</pub-id><pub-id pub-id-type="pmid">17366585</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Dobbelsteyn</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Peacocke</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Crist</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Rashid</surname>
<given-names>M</given-names></string-name>. <article-title>Feeding difficulties in children with CHARGE syndrome: prevalence, risk factors, and prognosis</article-title>. <source><italic toggle="yes">Dysphagia</italic></source>. <year>2008</year>;<volume>23</volume>(<issue>2</issue>):<fpage>127</fpage>&#x02013;<lpage>135</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00455-007-9111-6</pub-id><pub-id pub-id-type="pmid">18027028</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Hudson</surname>
<given-names>AS</given-names></string-name>. <article-title>Gastrointestinal and feeding difficulties in CHARGE syndrome: a review from head-to-toe</article-title>. <source><italic toggle="yes">Am J Med Genet Part C Semin Med Genet</italic></source>. <year>2017</year>;<volume>175</volume>(<issue>4</issue>):<fpage>496</fpage>&#x02013;<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.31586</pub-id><pub-id pub-id-type="pmid">29082627</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Dobbelsteyn</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Marche</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Rashid</surname>
<given-names>M</given-names></string-name>. <article-title>Early oral sensory experiences and feeding development in children with CHARGE syndrome: a report of five cases</article-title>. <source><italic toggle="yes">Dysphagia</italic></source>. <year>2005</year>;<volume>20</volume>(<issue>2</issue>):<fpage>89</fpage>&#x02013;<lpage>100</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00455-004-0026-1</pub-id><pub-id pub-id-type="pmid">16172816</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Hudson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Macdonald</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Friedman</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>K</given-names></string-name>. <article-title>CHARGE syndrome gastrointestinal involvement: from mouth to anus</article-title>. <source><italic toggle="yes">Clin Genet</italic></source>. <year>2017</year>;<volume>92</volume>(<issue>1</issue>):<fpage>10</fpage>&#x02013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cge.12892</pub-id><pub-id pub-id-type="pmid">28155231</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>K</given-names></string-name>, <string-name><surname>MacCuspie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hartshorne</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Roy</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Davenport</surname>
<given-names>SLH</given-names></string-name>, <string-name><surname>Corsten</surname>
<given-names>G</given-names></string-name>. <article-title>Postoperative airway events of individuals with CHARGE syndrome</article-title>. <source><italic toggle="yes">Int J Pediatr Otorhinolaryngol</italic></source>. <year>2008</year>;<volume>73</volume>(<issue>2</issue>):<fpage>219</fpage>&#x02013;<lpage>226</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijporl.2008.10.005</pub-id><pub-id pub-id-type="pmid">19058860</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Valla</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Berthiller</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gaillard-Le-Roux</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Faltering growth in the critically ill child: prevalence, risk factors, and impaired outcome</article-title>. <source><italic toggle="yes">Eur J Pediatr</italic></source>. <year>2018</year>;<volume>177</volume>(<issue>3</issue>):<fpage>345</fpage>&#x02013;<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00431-017-3062-1</pub-id><pub-id pub-id-type="pmid">29243190</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Hulst</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Joosten</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zimmermann</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Malnutrition in critically ill children: from admission to 6 months after discharge</article-title>. <source><italic toggle="yes">Clin Nutr</italic></source>. <year>2004</year>;<volume>23</volume>(<issue>2</issue>):<fpage>223</fpage>&#x02013;<lpage>232</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0261-5614(03)00130-4</pub-id><pub-id pub-id-type="pmid">15030962</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Corsten-Janssen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Scambler</surname>
<given-names>PJ</given-names></string-name>. <article-title>Clinical and molecular effects of CHD7 in the heart</article-title>. <source><italic toggle="yes">Am J Med Genet Part C Semin Med Genet</italic></source>. <year>2017</year>;<volume>175</volume>(<issue>4</issue>):<fpage>487</fpage>&#x02013;<lpage>495</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.31590</pub-id><pub-id pub-id-type="pmid">29088513</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Medoff-Cooper</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ravishankar</surname>
<given-names>C</given-names></string-name>. <article-title>Nutrition and growth in congenital heart disease: a challenge in children</article-title>. <source><italic toggle="yes">Curr Opin Cardiol</italic></source>. <year>2013</year>;<volume>28</volume>(<issue>2</issue>):<fpage>122</fpage>&#x02013;<lpage>129</lpage>. doi:<pub-id pub-id-type="doi">10.1097/HCO.0b013e32835dd005</pub-id><pub-id pub-id-type="pmid">23370229</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Ravishankar</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zak</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>IA</given-names></string-name>, et al. <article-title>Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the pediatric heart network infant single ventricle trial</article-title>. <source><italic toggle="yes">J Pediatr</italic></source>. <year>2013</year>;<volume>162</volume>(<issue>2</issue>):<page-range>256.e2</page-range>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2012.07.048</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Jain</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HG</given-names></string-name>, <string-name><surname>Lacbawan</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Unique phenotype in a patient with CHARGE syndrome</article-title>. <source><italic toggle="yes">Int J Pediatr Endocrinol</italic></source>. <year>2011</year>;<volume>2011</volume>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1687-9856-2011-11</pub-id><pub-id pub-id-type="pmid">21995344</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>D&#x000f6;rr</surname>
<given-names>HG</given-names></string-name>, <string-name><surname>Boguszewski</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dahlgren</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Short children with charge syndrome: do they benefit from growth hormone therapy?</article-title>
<source><italic toggle="yes">Horm Res Paediatr</italic></source>. <year>2015</year>;<volume>84</volume>(<issue>1</issue>):<fpage>49</fpage>&#x02013;<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000382017</pub-id><pub-id pub-id-type="pmid">26044035</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Bergman</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Janssen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hoefsloot</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Jongmans</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Hofstra</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>van Ravenswaaij-Arts</surname>
<given-names>CM</given-names></string-name>. <article-title>CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype</article-title>. <source><italic toggle="yes">J Med Genet</italic></source>. <year>2011</year>;<volume>48</volume>(<issue>5</issue>):<fpage>334</fpage>&#x02013;<lpage>342</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.2010.087106</pub-id><pub-id pub-id-type="pmid">21378379</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Balasubramanian</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Francescatto</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci USA</italic></source>. <year>2014</year>;<volume>111</volume>(<issue>50</issue>):<fpage>17953</fpage>&#x02013;<lpage>17958</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1417438111</pub-id><pub-id pub-id-type="pmid">25472840</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Costa-Barbosa</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Balasubramanian</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Keefe</surname>
<given-names>KW</given-names></string-name>, et al. <article-title>Prioritizing genetic testing in patients with kallmann syndrome using clinical phenotypes</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2013</year>;<volume>98</volume>(<issue>5</issue>):<page-range>E943; E953</page-range>. doi:<pub-id pub-id-type="doi">10.1210/jc.2012-4116</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cassatella</surname>
<given-names>D</given-names></string-name>, <string-name><surname>van der Sloot</surname>
<given-names>AM</given-names></string-name>, et al. <article-title>Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants</article-title>. <source><italic toggle="yes">Genet Med</italic></source>. <year>2018</year>;<volume>20</volume>(<issue>8</issue>):<fpage>872</fpage>&#x02013;<lpage>881</lpage>. doi:<pub-id pub-id-type="doi">10.1038/gim.2017.197</pub-id><pub-id pub-id-type="pmid">29144511</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Dunkel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Quinton</surname>
<given-names>R</given-names></string-name>. <article-title>Transition in endocrinology: induction of puberty</article-title>. <source><italic toggle="yes">Eur J Endocrinol</italic></source>. <year>2014</year>;<volume>170</volume>(<issue>6</issue>):<fpage>R239</fpage>. doi:<pub-id pub-id-type="doi">10.1530/EJE-13-0894</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Zirilli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Rochira</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Diazzi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Caffagni</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Carani</surname>
<given-names>C</given-names></string-name>. <article-title>Human models of aromatase deficiency</article-title>. <source><italic toggle="yes">J Steroid Biochem Mol Biol</italic></source>. <year>2008</year>;<volume>109</volume>(<issue>3&#x02013;5</issue>):<fpage>212</fpage>&#x02013;<lpage>218</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsbmb.2008.03.026</pub-id><pub-id pub-id-type="pmid">18448329</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Russell-Eggitt</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Morgan</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Ratcliffe</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Wyse</surname>
<given-names>RK</given-names></string-name>. <article-title>Who&#x02019;s in CHARGE? Multidisciplinary management of patients with CHARGE association</article-title>. <source><italic toggle="yes">Arch Dis Child</italic></source>. <year>1990</year>;<volume>65</volume>(<issue>2</issue>):<fpage>217</fpage>&#x02013;<lpage>223</lpage>. doi:<pub-id pub-id-type="doi">10.1136/adc.65.2.217</pub-id><pub-id pub-id-type="pmid">2317068</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Blake</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Prasad</surname>
<given-names>C</given-names></string-name>. <article-title>CHARGE syndrome</article-title>. <source><italic toggle="yes">Orphanet J Rare Dis</italic></source>. <year>2006</year>;<volume>1</volume>:<fpage>34</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1750-1172-1-34</pub-id><pub-id pub-id-type="pmid">16959034</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>White</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Cooley</surname>
<given-names>WC</given-names></string-name>. <article-title>Supporting the health care transition from adolescence to adulthood in the medical home</article-title>. <source><italic toggle="yes">Pediatrics</italic></source>. <year>2018</year>;<volume>142</volume>:<fpage>5</fpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2018-2587</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Van Lierde</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Menni</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bedeschi</surname>
<given-names>MF</given-names></string-name>, et al. <article-title>Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams-Beuren syndrome</article-title>. <source><italic toggle="yes">Am J Med Genet A</italic></source>. <year>2013</year>;<volume>161A</volume>(<issue>7</issue>):<fpage>1666</fpage>&#x02013;<lpage>1674</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.35982</pub-id><pub-id pub-id-type="pmid">23696535</pub-id></mixed-citation></ref><ref id="CIT0054"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Hughes-McCormack</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Rydzewska</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Henderson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>MacIntyre</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rintoul</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cooper</surname>
<given-names>S</given-names></string-name>. <article-title>Prevalence and general health status of people with intellectual disabilities in Scotland: a total population study</article-title>. <source><italic toggle="yes">J Epidemiol Community Health</italic></source>. <year>2018</year>;<volume>72</volume>(<issue>1</issue>):<fpage>78</fpage>&#x02013;<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jech-2017-209748</pub-id><pub-id pub-id-type="pmid">29070675</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Krahn</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Hammond</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Turner</surname>
<given-names>A</given-names></string-name>. <article-title>A cascade of disparities: health and health care access for people with intellectual disabilities</article-title>. <source><italic toggle="yes">Ment Retard Dev Disabil Res Rev</italic></source>. <year>2006</year>;<volume>12</volume>(<issue>1</issue>):<fpage>70</fpage>&#x02013;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mrdd.20098</pub-id><pub-id pub-id-type="pmid">16435327</pub-id></mixed-citation></ref><ref id="CIT0056"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Franklin</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Beyer</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Brotkin</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Maslow</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Pollock</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Docherty</surname>
<given-names>SL</given-names></string-name>. <article-title>Health care transition for adolescent and young adults with intellectual disability: views from the parents</article-title>. <source><italic toggle="yes">J Pediatr Nurs</italic></source>. <year>2019</year>;<volume>47</volume>:<fpage>148</fpage>&#x02013;<lpage>158</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pedn.2019.05.008</pub-id><pub-id pub-id-type="pmid">31152999</pub-id></mixed-citation></ref><ref id="CIT0057"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Gabriel</surname>
<given-names>P</given-names></string-name>, <string-name><surname>McManus</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rogers</surname>
<given-names>K</given-names></string-name>, <string-name><surname>White</surname>
<given-names>P</given-names></string-name>. <article-title>Outcome evidence for structured pediatric to adult health care transition interventions: a systematic review</article-title>. <source><italic toggle="yes">J Pediatr</italic></source>. <year>2017</year>;<volume>188</volume>:<page-range>269.e15</page-range>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2017.05.066</pub-id></mixed-citation></ref><ref id="CIT0058"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Schrander-Stumpel</surname>
<given-names>CTRM</given-names></string-name>, <string-name><surname>Sinnema</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van Den Hout</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Healthcare transition in persons with intellectual disabilities: general issues, the Maastricht model, and Prader-Willi syndrome</article-title>. <source><italic toggle="yes">Am J Med Genet C Semin Med Genet</italic></source>. <year>2007</year>;<volume>145C</volume>(<issue>3</issue>):<fpage>241</fpage>&#x02013;<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.30136</pub-id><pub-id pub-id-type="pmid">17639594</pub-id></mixed-citation></ref><ref id="CIT0059"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Peron</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Canevini</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Ghelma</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Di Marco</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vignoli</surname>
<given-names>A</given-names></string-name>. <article-title>Healthcare transition from childhood to adulthood in tuberous sclerosis complex</article-title>. <source><italic toggle="yes">Am J Med Genet C Semin Med Genet</italic></source>. <year>2018</year>;<volume>178</volume>(<issue>3</issue>):<fpage>355</fpage>&#x02013;<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.31653</pub-id><pub-id pub-id-type="pmid">30253036</pub-id></mixed-citation></ref><ref id="CIT0060"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Craig</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fayter</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stirk</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Crott</surname>
<given-names>R</given-names></string-name>. <article-title>Growth monitoring for short stature: update of a systematic review and economic model</article-title>. <source><italic toggle="yes">Health Technol Assess</italic></source>. <year>2011</year>;<volume>15</volume>(<issue>11</issue>):<fpage>iii</fpage>.</mixed-citation></ref><ref id="CIT0061"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Victora</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Adair</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fall</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Maternal and child undernutrition: consequences for adult health and human capital</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2008</year>;<volume>371</volume>(<issue>9609</issue>):<fpage>340</fpage>&#x02013;<lpage>357</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(07)61692-4</pub-id><pub-id pub-id-type="pmid">18206223</pub-id></mixed-citation></ref><ref id="CIT0062"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Martorell</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Horta</surname>
<given-names>BL</given-names></string-name>, <string-name><surname>Adair</surname>
<given-names>LS</given-names></string-name>, et al. <article-title>Weight gain in the first two years of life is an important predictor of schooling outcomes in pooled analyses from five birth cohorts from low- and middle-income countries</article-title>. <source><italic toggle="yes">J Nutr</italic></source>. <year>2010</year>;<volume>140</volume>(<issue>2</issue>):<fpage>348</fpage>&#x02013;<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.3945/jn.109.112300</pub-id><pub-id pub-id-type="pmid">20007336</pub-id></mixed-citation></ref><ref id="CIT0063"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Trider</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Arra-Robar</surname>
<given-names>A</given-names></string-name>, <string-name><surname>van Ravenswaaij-Arts</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>K</given-names></string-name>. <article-title>Developing a CHARGE syndrome checklist: health supervision across the lifespan (from head to toe)</article-title>. <source><italic toggle="yes">Am J Med Genet Part A</italic></source>. <year>2017</year>;<volume>173</volume>(<issue>3</issue>):<fpage>684</fpage>&#x02013;<lpage>691</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.38085</pub-id><pub-id pub-id-type="pmid">28160409</pub-id></mixed-citation></ref><ref id="CIT0064"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>de Geus</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Free</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Verbist</surname>
<given-names>BM</given-names></string-name>, et al. <article-title>Guidelines in CHARGE syndrome and the missing link: cranial imaging</article-title>. <source><italic toggle="yes">Am J Med Genet Part C Semin Med Genet</italic></source>. <year>2017</year>;<volume>175</volume>(<issue>4</issue>):<fpage>450</fpage>&#x02013;<lpage>464</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.c.31593</pub-id><pub-id pub-id-type="pmid">29168326</pub-id></mixed-citation></ref><ref id="CIT0065"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Wincent</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Holmberg</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Stromland</surname>
<given-names>K</given-names></string-name>, et al. <article-title>CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome</article-title>. <source><italic toggle="yes">Clin Genet</italic></source>. <year>2008</year>;<volume>74</volume>(<issue>1</issue>):<fpage>31</fpage>&#x02013;<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.01014.x</pub-id><pub-id pub-id-type="pmid">18445044</pub-id></mixed-citation></ref><ref id="CIT0066"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Delahaye</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sznajer</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lyonnet</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability</article-title>. <source><italic toggle="yes">Clin Genet</italic></source>. <year>2007</year>;<volume>72</volume>(<issue>2</issue>):<fpage>112</fpage>&#x02013;<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1399-0004.2007.00821.x</pub-id><pub-id pub-id-type="pmid">17661815</pub-id></mixed-citation></ref><ref id="CIT0067"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Pauli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pieper</surname>
<given-names>L</given-names></string-name>, <string-name><surname>H&#x000e4;berle</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Proven germline mosaicism in a father of two children with CHARGE syndrome</article-title>. <source><italic toggle="yes">Clin Genet</italic></source>. <year>2009</year>;<volume>75</volume>(<issue>5</issue>):<fpage>473</fpage>&#x02013;<lpage>479</lpage>.<pub-id pub-id-type="pmid">19475719</pub-id></mixed-citation></ref></ref-list></back></article>